WASHINGTON, May 21, 2021 – Today the Alliance for Aging Research sent a letter to Democratic members in the U.S. House of Representatives that have advocated for a bipartisan, bicameral approach to addressing prescription drug costs. In the letter, the Alliance encouraged Representatives to address patients’ ability to afford their prescribed medications, while also continuing to support policies that advance equity and foster research into cures for the most challenging diseases such as Alzheimer’s disease.
The Alliance’s letter can be found here.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org